توثيق جمعية علم النفس الأمريكية APA (الطبعة السابعة)

Y, W., G, G., X, W., Y, Z., & J, Y. (2023, May). UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway. Drug Design, Development and Therapy.

توثيق أسلوب شيكاغو (الطبعة السابعة عشر)

Y, Wang, Gao G, Wei X, Zhang Y, و Yu J. "UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway." Drug Design, Development and Therapy May. 2023.

توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)

Y, Wang, et al. "UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway." Drug Design, Development and Therapy, May. 2023.